NCT01340066View on ClinicalTrials.gov

Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Urinary Incontinence
Interventions
DRUG

UISH001

sublingual dosing, 1 drop 3 times a day

DRUG

matching placebo

sublingual dosing,1 drop 3 times a day

Trial Locations (3)

13760

Regional Clinical Research, Inc., Endwell

14609

Rochester Clinical Research, Rochester

15241

PEAK Research, LLC, Upper Saint Clair

Sponsors
All Listed Sponsors
collaborator

Norwich Clinical Research Associates Ltd.

OTHER

lead

Beech Tree Labs, Inc.

INDUSTRY